Corporate supporters

ABCD  is grateful to  its corporate supporters for their financial support which supports the activities of the Charity and allows the Association of British Clinical Diabetologists to make its services either freely available or at greatly reduced rates to its members.

We would like to invite pharmaceutical companies to become a corporate supporters of ABCD - click here

We would like to invite companies that make insulin pumps and other devices to become corporate supporters of ABCD - click here

ABCD Corporate Pharma Supporters

Gold sponsors

The Boehringer Ingelheim and Lilly Diabetes Alliance

The Alliance leverages the companies’ strengths as two of the world’s leading pharmaceutical companies, combining Boehringer Ingelheim’s solid track record of research-driven innovation and Lilly’s innovative research, experience, and pioneering history in diabetes.

By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs. Find out more about the Alliance at or


At Janssen, we are dedicated to addressing and solving some of the most important unmet medical needs of our time in cardiovascular and metabolic diseases, oncology, immunology, neuroscience, vaccines and infectious diseases. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen-Cilag Limited is the legal entity for Janssen in the UK.

JanssenPro® is an online portal for UK based HCPs, where you can access treatment information, medical education, medical news, and support that you can trust.  Visit

Merck Sharp & Dohme Ltd
Today's MSD is a global healthcare leader working to help the world be well. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, NJ, USA. Through our prescription medicines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programmes and partnerships. For more information, visit

Novo Nordisk Ltd

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.  Headquartered in Denmark, Novo Nordisk employs approximately 40,300 people in 75 countries, and markets its products in more than 180 countries.

Novo Nordisk shows responsibility to patients, employees, communities and investors.  We will continue to build on the legacy left by the founders of Novo Nordisk and do whatever it takes to change diabetes.  Novo Nordisk is committed to improving the lives of people living with diabetes. We take an innovative approach by addressing the challenges of diabetes as a whole, working with doctors, nurses and patient organisations to empower people with diabetes to self-manage their condition and improve their long-term health.


Sanofi Diabetes

Sanofi strives to help people manage the complex challenge of diabetes by delivering innovative, integrated and personalized solutions. Driven by valuable insights that come from listening to and engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services and devices, including intelligent blood glucose monitoring systems. Sanofi markets both injectable and oral medications for people with Type 1 or Type 2 diabetes.


Takeda UK Ltd

Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Takeda UK Ltd., located in High Wycombe, is the UK marketing and sales organisation of Takeda Pharmaceutical Company Limited.  Additional information about Takeda UK Ltd. is available through its website,

Silver sponsors
Bronze sponsors


AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.


ABCD Corporate Pump and Device Supporters

Gold sponsors  


Combining the latest in insulin pump technology with m-Health Cellnovo is proud to have developed our mobile diabetes management system in the UK and launched in 2014 at selected UK centres. Cellnovo products are manufactured in South Wales and having secured additional funding through an IPO in 2015, we are now able to offer the system to a growing number of centres in the UK and Europe. The Cellnovo system incorporates a miniaturised insulin pump with a discrete, tubeless, small and wearable device. It also allows patients to capture blood glucose readings, carbohydrate intake, bolus calculations, and activity levels. A first in insulin pump therapy, the system communicates data from the users pump, automatically to a secure online platform. This allows both patients and clinicians immediate access to real time diabetes management data and removes downloading requirements. For more information visit

Diasend AB

Diasend simplifies life for people with diabetes and facilitates the work of their health care providers by optimizing diabetes data management. Thecompany’s comprehensive and market leading solution involves transmitting, storing and analyzing data from more than 130 different glucose meters,insulin pumps, CGM systems (continuous glucose monitoring) and leading activity trackers – allowing patients and caregivers to easily access the exactsame information. Diasend’s products and services, all FDA-approved and CE-marked, are currently used in 17 countries. Headquarters are located inGothenburg, Sweden – with subsidiaries in Chicago and London. For more information please visit Diasend

Roche Diabetes Care
Roche Diabetes Care is a global leader for innovative diabetes management solutions. For more than 40 years, the company has been dedicated to empower people with diabetes and healthcare professionals to optimally manage the condition. Today, the Accu-Chek portfolio encompasses smart solutions for bG monitoring, bolus advice and discreet remote control insulin pump technology with the Accu-Chek Combo and Accu-Chek Insight systems. Accu-Chek solutions contribute to optimal and personalised diabetes management, leading to improved outcomes and contributing to therapy success for people with diabetes.


Silver sponsors                               

Abbott Diabetes Care

 At Abbott, we’re committed to helping you live your best possible life through the power of health. For more than 125 years, we’ve brought new products and technologies to the world -- in nutrition, diagnostics, medical devices and branded generic pharmaceuticals -- that create more possibilities for more people at all stages of life. Today, 74,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.



With a shared vision of “creating a world without limits” for people with diabetes, Animas Corporation is a part of the Johnson & Johnson Diabetes Care Companies (JJDCC), a cross-company collaboration that reflects an ongoing commitment to better serve the diabetes community with integrated solutions that meet the needs of people with diabetes across the continuum of care. JJDCC includes LifeScan, Inc., a world leader in blood glucose monitoring; Calibra Medical, Inc. developer of a unique 3-day wearable insulin patch, and Animas Corporation, which provides a wide range of insulin delivery products for people living with diabetes, including the Animas ®  Vibe®  Insulin Pump and Continuous Glucose Monitoring (CGM) system, and the OneTouch®  Ping® Glucose Management System. Animas, from the Latin word meaning “true inner self or soul,” has been committed since 1996 to meeting individual patient needs through the development of life-performance technology and customer service 24 hours a day, 7 days a week, 365 days a year. To learn more about Animas, visit

Medtronic Ltd

Medtronic was founded in 1949.  Since then we have grown into a multinational company that uses technology to transform the way debilitating, chronic diseases are treated. Effective diabetes management and monitoring tools like the MinIMed® 640G with SmartGuard® and CareLink® Therapy Management Software can help people living with diabetes lead a full and active life.

To find out more about Medtronic’s diabetes products, services and support for healthcare professional, patients and carers please visit: . Medtronic UK offices are based in Watford, Herts

Bronze sponsors  

Dexcom, Inc., headquartered in San Diego, CA, soon to be direct in the UK, is dedicated to helping people better manage their diabetes by providing exceptional continuous glucose monitoring (CGM) products and tools for adult and pediatric patients. Our latest-generation CGM, the Dexcom G5® Mobile CGM System, is the first FDA-approved, fully mobile System for both adults and children 2 years and older. Patients can view not only their real-time glucose data via their hand held Receiver or compatible smartphone* but also share it with loved ones.  Our CGM features a 7-day-wear sensor as well as customizable alerts and a built-in low alarm to warn patients of the speed and direction of highs and lows. For more information, visit

*To view a listing of compatible smartphones, visit

The sponsoring pharmaceutical companies are not responsible for the content of this website.

Click HERE to view the ABCD statement on pharmaceutical industry funding